Guidance for 2026 EPS increased from a reaffirmed 2025 outlook of at least $29.60 per share in Q3 to at least $30.25 per share for 2026 in Q4.

This evening President Trump is planning to launch TrumpRx, the website that he's touted for months as a platform aimed at lowering prescription drug prices.

Traditional typewriter typefaces are a must in any font collection.

For decades, the idea of saving Earth from an incoming asteroid with nuclear weapons lived mostly in popcorn cinema, a ...

Based on ads released in advance of the Super Bowl, little has changed in the eyes of the pharma industry since the FDA began ...

The US Federal Trade Commission has hailed what it calls a ‘landmark settlement’ with one of the nation’s largest pharmacy ...

The agreement announced Wednesday includes sweeping changes to the Cigna PBM’s business practices, including no longer preferring expensive drugs over cheaper equivalents on standard formularies and ...

Tencent Cloud EdgeOne's new AI Crawler Control solves this by utilizing advanced User-Agent feature recognition. The system continuously updates its identification rules to pinpoint mainstream AI bots ...